Cannabinoid CBG

The administration of the nonpsychotropic plant cannabinoid CBD-deficiency-meme-300cannabigerol (CBG) has potent anti-colon cancer activities and inhibits cancerous tumor growth, according to data published in September in the journal Carcinogenesis. A team of Italian researchers at the University of Naples assessed the effects of CBG on colon tumorigenesis. Investigators reported that the compound promoted apoptosis (cancer cell death) and reduced cell growth in colorectal cancer cells. CBG dosing also inhibited colorectal tumor growth in animals. Authors concluded: “CBG hampers colon cancer progression in vivo and selectively inhibits the growth of colorectal cancer cells. … CBG should be considered translationally in colorectal cancer prevention and cure.”

Read entire article: http://www.alternet.org/drugs/latest-cannabis-science-mainstream-media-doesnt-want-you-know

Source:  by Paul Armentano  Alternet.org